Zoetis Animal Health: Vet Practice Perspective
Former Director at Banfield Pet Hospital
inpractise.com/articles/zoetis-animal-health-vet-practice-perspective
Former Director at Banfield Pet Hospital
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Have you heard of vets switching from IDEXX to Zoetis or adding one or two analyzers from Zoetis?
I work with hospitals who often switch from Antech to IDEXX, but that has to do with preferred providers. The preferred external lab for MARS is Antech, whereas the corporate group I am current with use IDEXX. When I speak to veterinarians about why they prefer one over the other, there are examples where IDEXX has the upper hand with innovation in how their readouts sync with their hospital software system. I have also heard veterinarians enjoy Antech's telephone support specialists. That may be a local and regional difference, but Antech has hired specialists to support hospitals.
This is a snippet of the transcript, sign up to read more.
Related Content
Zoetis, IDEXX Laboratories and Animal Diagnostics Competition
Former Commercial Executive at Zoetis and IDEXX Laboratories
Zoetis, BI, Elanco & Animal Pharma Competition
Former Senior Director at Elanco
IDEXX Laboratories: UK Vet Practices, Diagnostics & Practice Management Software
Director at UK Independent Vet Practice
Weekly Update: Expert Networks & Commoditised 1-1s: Misaligned Incentives
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.